Common Stock, Shares, Outstanding of Hoth Therapeutics, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Hoth Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Hoth Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 15,127,622, a 119% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Hoth Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 15,127,622 +8,223,818 +119% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 13,234,027 +7,875,223 +147% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 13,170,715 +8,766,911 +199% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 8,042,747 +3,694,618 +85% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 6,903,804 +2,557,366 +59% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 5,358,804 +2,056,691 +62% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 4,403,804 +1,101,691 +33% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 4,348,129 +3,046,016 +234% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 4,346,438 +3,057,945 +237% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 3,302,113 -28,908,831 -90% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 3,302,113 -20,672,985 -86% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 1,302,113 +343,104 +36% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 1,288,493 -22,685,501 -95% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 32,210,944 +8,338,211 +35% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 23,975,098 +872,974 +3.8% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 959,009 -12,479,526 -93% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 23,973,994 +10,538,093 +78% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 23,872,733 +10,439,466 +78% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 23,102,124 +11,508,423 +99% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 13,438,535 +3,318,691 +33% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 13,435,901 +3,318,139 +33% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 13,433,267 +3,765,011 +39% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 11,593,701 +2,167,737 +23% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 10,119,844 +5,048,444 +100% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 10,117,762 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 9,668,256 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 9,425,964 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 5,071,400 +365,123 +7.8% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 4,706,277 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.